Universe Pharmaceuticals INC Holds Shareholder Meeting
Ticker: UPC · Form: 6-K · Filed: Mar 11, 2025 · CIK: 1809616
| Field | Detail |
|---|---|
| Company | Universe Pharmaceuticals INC (UPC) |
| Form Type | 6-K |
| Filed Date | Mar 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance, filing-update
TL;DR
Universe Pharma held its shareholder meeting on March 8th after a prior postponement.
AI Summary
Universe Pharmaceuticals INC held an extraordinary general meeting of shareholders on March 8, 2025, which was a re-convening of a meeting originally scheduled for March 1, 2025. The meeting took place at 10:00 a.m. Beijing Time at the company's address in Ji'an, Jiangxi, China.
Why It Matters
This filing indicates corporate governance activity, specifically the outcome of a shareholder meeting, which can influence investor confidence and future company decisions.
Risk Assessment
Risk Level: low — The filing is a routine report of a shareholder meeting and does not contain significant financial or operational news.
Key Players & Entities
- Universe Pharmaceuticals INC (company) — Registrant
- March 8, 2025 (date) — Date of re-convened extraordinary general meeting
- March 1, 2025 (date) — Original date of extraordinary general meeting
- Ji'an, Jiangxi, China (location) — Company's principal executive offices
FAQ
What was the purpose of the March 2025 Extraordinary General Meeting?
The filing does not specify the purpose of the meeting, only that it was re-convened.
Why was the extraordinary general meeting originally convened on March 1, 2025, re-convened on March 8, 2025?
The filing states the meeting was re-convened but does not provide the reason for the re-convening.
What is the company's fiscal year end?
The company's fiscal year ends on September 30 (0930).
Under which form does the registrant file its annual reports?
The registrant files its annual reports under cover of Form 20-F.
What is the SIC code for Universe Pharmaceuticals INC?
The Standard Industrial Classification (SIC) code for Universe Pharmaceuticals INC is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 11, 2025 regarding Universe Pharmaceuticals INC (UPC).